Analytical Data
-
Gene name
M317MC
- Application
-
Species
Human
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P48431
-
Expression Region
1-317aa((M317MC)
-
Molecular Weight
40.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The M317MC recombinant protein is a significant focus of research due to its potential applications in various fields, including medicine and biotechnology. This protein is derived from the M317MC strain of bacteria, which is known for its unique properties that can be harnessed for therapeutic purposes. Investigating the structure and function of M317MC protein can yield insights into its biochemical pathways, interactions, and biological roles. Recent studies have highlighted its role in pathogen resistance, making it a promising candidate for developing new antibiotics or vaccines. Additionally, understanding M317MC's molecular mechanisms can pave the way for innovations in protein engineering, enhancing its efficacy and utility in drug delivery systems. The production of this recombinant protein using advanced biotechnological methods ensures its availability for extensive research, allowing scientists to explore its potential in combating infectious diseases and other health challenges. As the global demand for effective therapeutic agents continues to rise, M317MC recombinant protein stands out as a key player in the ongoing quest for novel solutions in pharmaceutical development.
